Abstract:Objective: The prevalence of non-alcoholic fatty liver disease (NAFLD) has markedly increased. Insulin resistance has been implicated in the pathogenesis of NAFLD. This study was aimed at observing the relationship between insulin resistance and NAFLD, and evaluating the role of pioglitazone (PGZ) acting as insulin-sensitizing agents in the prevention and treatment of rat fatty liver induced by high fat feeding. Methods: The rats were separated randomly into 6 groups: model group I were fed high fat diet for 8 weeks, PGZ prevention group were given PGZ 4 mg/(kg·d) simultaneously, while control group I were fed normal food for 8 weeks; model group II were fed high fat diet for 16 weeks, PGZ treatment group were given PGZ 4 mg/(kg·d) orally simultaneous with high fat diet for 8 weeks after high fat feeding for 8 weeks, control group II were fed normal food for 16 weeks. The rats were sacrificed after 8 weeks and 16 weeks respectively. Liver weight, body weight, serum activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), tumor necrosis factor alpha (TNF-α), fasting blood glucose (FBG), fasting plasma insulin (FINS), HOMA (homeostasis model assessment) insulin resistance index (HOMA-IR), and the liver histology of rats of all groups were assayed. Results: After 8 weeks, the liver in model group I showed typical steatosis, accompanied with mild to moderate lobular inflammatory cell infiltration, liver indexes and serum levels of ALT, AST, ALP, TNF-α were significantly increased ( P <0.05) compared with control group I. Whereas, the degree of hepatic injury was attenuated in PGZ prevention group, liver indexes and serum levels of ALT, ALP were significantly decreased ( P <0.05) compared with model group I. After 16 weeks, notable steatosis, and lobular inflammation were observed in model group II rat liver, while the degree of hepatic injury was attenuated in the PGZ treatment group. Liver index, serum levels of ALT, AST, ALP, FINS and HOMA-IR were significantly increased ( P <0.05) in model group II compared with control group II. Whereas, in PGZ treatment group, serum levels of AST and FINS showed decreasing tendency, liver indexes, serum levels of ALT, ALP, TNF-α and HOMA-IR were significantly decreased compared with model group II. Conclusion: Insulin resistance plays a role in the pathogenesis of NAFLD in rats. Pioglitazone can attenuate insulin resistance and biochemical and histological injury in high fat-induced fatty liver in rats.

Effect of Modified Didang Decoction on T-Pa,pai-1 and PAl-1 Gene Express in Fat in InsuIin Resistance Rats

Effect of Modified Didang Decoction on PAI-1 Gene Expression in Liver in Insulin Resistance Rats

Effect of DM120 Recipe on Expression of Transforming Growth Factor β1 in Renal Tissue of Diabetic Rats

Effect of Tangzhiping on Serum Adiponectin Level and the mRNA Expression of Adiponectin in Epididymal Fat Pads in Rats with insulin Resistance

Impacts of Tangzhiping on Genetic Expressions of PGC - 1α,Cytochrome C and ATP Synthases β Subunit in the Rats of Insulin Resistance

The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance

Effect of Tangzhiping on Serum TNF-α Level and mRNA Expression of TNF-α in Epididymal Fat Pads in Rats with Insulin Resistance

[Preventive Effects of Pioglitazone on Rat Fatty Liver Induced by a High Fat Diet].

Research on the Protection Effect of Pioglitazone for Non-Alcoholic Fatty Liver Disease (NAFLD) in Rats

Effects of shenqi decoction on the gene expression of endothelins in rats with myocardial ischemia

Impact of Tangzhiping on Lipid Metabolism and Adipokine in the Rats of Insulin Resistance

Ang-(1-7) Improves Islet B Cell Function By Up-Regulating The Activity Of Ang-(1-7)-Mas Axis/Pdx-1

Ameliorating Inflammation in Insulin-resistant Rat Adipose Tissue with Abdominal Massage Regulates SIRT1/NF-κB Signaling

Impacts of Tangzhiping on Glucose and Insulin Metabolism in the Rats of Insulin Resistance

Expression of Plasminogen Activator Inhibitor-1 in Kidney of Diabetic Rats and Its Modulation by Tongxinluo Capsule

Effects of Tangzhiping on Glucose and Lipid Metabolism in Insulin-Resistance Rat Model

Effect of Qidi Xiaoke Prescription on C-peptide, Tumor Necrosis Factor-α, Interleukin-6, and Histopathological Changes of the Spleen in Rats with Type 2 Diabetes with Deficiency of Both Qi and Yin

The Effect of Tangzhiping on Glycemic and Lipid Metabolism and Insulin Sensitivity in Rat Insulin Resistance Model

Effects of Modified Sanzi Yangqin Decoction on Tyrosine Phosphorylation of IRS-1 in Skeletal Muscle of Type 2 Diabetic Rats

Impacts of Tangzhiping on AMPK/PGC - 1α Signaling Pathway in the Rats of Insulin Resistance

[The Expression of Insulin Signal Transduction Molecules and Islet Alpha Cell Insulin Resistance].